These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25720452)

  • 1. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.
    Wigren M; Nilsson J; Kaplan MJ
    J Intern Med; 2015 Nov; 278(5):494-506. PubMed ID: 25720452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.
    Yao Mattisson I; Rattik S; Björkbacka H; Ljungcrantz I; Terrinoni M; Lebens M; Holmgren J; Fredrikson GN; Gullstrand B; Bengtsson AA; Nilsson J; Wigren M
    Vascul Pharmacol; 2021 Oct; 140():106863. PubMed ID: 33857652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
    Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
    Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in systemic lupus erythematosus: an update.
    Liu Y; Kaplan MJ
    Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
    Tumurkhuu G; Montano E; Jefferies C
    Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
    J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
    Turano L
    J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
    Gustafsson JT; Svenungsson E
    Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis in systemic lupus erythematosus.
    Croca S; Rahman A
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers.
    Guzmán-Martínez G; Marañón C;
    Front Immunol; 2022; 13():974826. PubMed ID: 36420265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis in Systemic Lupus Erythematosus.
    Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
    Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
    Kahlenberg JM; Kaplan MJ
    Annu Rev Med; 2013; 64():249-63. PubMed ID: 23020882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    J Intern Med; 2023 Jan; 293(1):48-62. PubMed ID: 35982610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated atherosclerosis in patients with SLE--mechanisms and management.
    Skaggs BJ; Hahn BH; McMahon M
    Nat Rev Rheumatol; 2012 Feb; 8(4):214-23. PubMed ID: 22331061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.